NMRA Competitors & Alternatives
Compare Neumora Therapeutics, Inc. with similar stocks in the same industry
Biotechnology
NMRA
Main Stock$1.67
Tradestie Score
59
Market Cap
$288.26M
Analyst Upside
+291.2%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
REPL
Replimune Group, Inc.
|
$11.58
|
$328.62M | - | 58 | Compare |
|
EDIT
Editas Medicine, Inc. Common Stock
|
$3.65
|
$319.22M | - | 55 | Compare |
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$15.10
|
$308.74M | - | 60 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$9.83
|
$304.12M | - | 59 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$21.51
|
$297.23M | - | 58 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$37.93
|
$293.03M | - | 64 | Compare |
|
OMER
Omeros Corporation
|
$9.28
|
$281.75M | 8.3 | 51 | Compare |
|
DBVT
DBV Technologies S.A.
|
$15.82
|
$275.54M | - | 55 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$2.08
|
$275.13M | - | 55 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$20.59
|
$269.08M | - | 57 | Compare |
More NMRA Analysis
Data updated: Jul 02, 2026 | Industry: Biotechnology (SIC 2836)
233 stocks in this industry